Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview
出版年份 2021 全文链接
标题
Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 11, Pages 6047
出版商
MDPI AG
发表日期
2021-06-03
DOI
10.3390/ijms22116047
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Doubling up on function: dual-specificity tyrosine-regulated kinase 1A (DYRK1A) in B cell acute lymphoblastic leukemia
- (2021) Jung-Hyun Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3
- (2021) Rahul S. Bhansali et al. JOURNAL OF CLINICAL INVESTIGATION
- Properties of FDA-approved small molecule protein kinase inhibitors: a 2021 update
- (2021) Robert Roskoski PHARMACOLOGICAL RESEARCH
- TROAP switches DYRK1 activity to drive hepatocellular carcinoma progression
- (2021) Lei Li et al. Cell Death & Disease
- Multi-influential genetic interactions alter behaviour and cognition through six main biological cascades in Down syndrome mouse models
- (2021) Arnaud Duchon et al. HUMAN MOLECULAR GENETICS
- DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes
- (2021) Kunal Kumar et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis
- (2021) Y. Yazici et al. OSTEOARTHRITIS AND CARTILAGE
- Oncogenic B-Myb Is Associated With Deregulation of the DREAM-Mediated Cell Cycle Gene Expression Program in High Grade Serous Ovarian Carcinoma Clinical Tumor Samples
- (2021) Audra N. Iness et al. Frontiers in Oncology
- Dual Specificity Kinase DYRK3 Promotes Aggressiveness of Glioblastoma by Altering Mitochondrial Morphology and Function
- (2021) Kyeongmin Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Progesterone Receptors Promote Quiescence & Ovarian Cancer Cell Phenotypes via DREAM in p53-Mutant Fallopian Tube Models
- (2021) Laura J Mauro et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A subcellular map of the human kinome
- (2021) Haitao Zhang et al. eLife
- Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup® Dietary Supplement: Role of Green Tea Catechins
- (2020) Yuchen Gu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Synthesis and Biological Validation of a Harmine-Based, Central Nervous System (CNS)-Avoidant, Selective, Human β-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor
- (2020) Kunal Kumar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133
- (2020) Yahu A. Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Conserved Kinase-Based Body-Temperature Sensor Globally Controls Alternative Splicing and Gene Expression
- (2020) Tom Haltenhof et al. MOLECULAR CELL
- Leishmania dual‐specificity tyrosine‐regulated kinase 1 (DYRK1) is required for sustaining Leishmania stationary phase phenotype
- (2020) Vinícius Pinto Costa Rocha et al. MOLECULAR MICROBIOLOGY
- Two drugs converged in a pancreatic β cell
- (2020) Marissa A. Scavuzzo et al. Science Translational Medicine
- GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration
- (2020) Courtney Ackeifi et al. Science Translational Medicine
- Altered Hippocampal-Prefrontal Neural Dynamics in Mouse Models of Down Syndrome
- (2020) Pishan Chang et al. Cell Reports
- The Natural Metabolite 4-Cresol Improves Glucose Homeostasis and Enhances β-Cell Function
- (2020) Francois Brial et al. Cell Reports
- Host factor prioritization for pan-viral genetic perturbation screens using random intercept models and network propagation
- (2020) Simon Dirmeier et al. PLoS Computational Biology
- Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases
- (2020) Alejandro Correa-Sáez et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Overexpression of miR-26a-5p suppresses Tau phosphorylation and Aβ accumulation in Alzheimer's disease mice by targeting DYRK1A
- (2020) Yanni Liu et al. CURRENT NEUROVASCULAR RESEARCH
- Impairment of DYRK2 by DNMT1‑mediated transcription augments carcinogenesis in human colorectal cancer
- (2020) Tomotaka Kumamoto et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Characterization of unconventional kinetochore kinases KKT10 and KKT19 in Trypanosoma brucei
- (2020) Midori Ishii et al. JOURNAL OF CELL SCIENCE
- DYRK kinase Pom1 drives F-BAR protein Cdc15 from the membrane to promote medial division
- (2020) Rahul Bhattacharjee et al. MOLECULAR BIOLOGY OF THE CELL
- Structure–Activity Relationships and Biological Evaluation of 7-Substituted Harmine Analogs for Human β-Cell Proliferation
- (2020) Kunal Kumar et al. MOLECULES
- The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo
- (2020) L. Trovò et al. NEUROBIOLOGY OF DISEASE
- Identification of a small molecule that stimulates human β-cell proliferation and insulin secretion, and protects against cytotoxic stress in rat insulinoma cells
- (2020) Hans E. Hohmeier et al. PLoS One
- Molecular dissection of chagas induced cardiomyopathy reveals central disease associated and druggable signaling pathways
- (2020) Jacob M. Wozniak et al. PLoS Neglected Tropical Diseases
- An atypical DYRK kinase connects quorum-sensing with posttranscriptional gene regulation in Trypanosoma brucei
- (2020) Mathieu Cayla et al. eLife
- Lorecivivint, a Novel Intra‐articular CLK/DYRK1A Inhibitor and Wnt Pathway Modulator for Treatment of Knee Osteoarthritis: A Phase 2 Randomized Trial
- (2020) Yusuf Yazici et al. Arthritis & Rheumatology
- Low UV-C stress modulates Chlamydomonas reinhardtii biomass composition and oxidative stress response through proteomic and metabolomic changes involving novel signalers and effectors
- (2020) Francisco Colina et al. Biotechnology for Biofuels
- A Dual Inhibitor of DYRK1A and GSK3β for β‐Cell Proliferation: Aminopyrazine Derivative GNF4877
- (2020) Yahu A. Liu et al. ChemMedChem
- Simplified detection of polyhistidine-tagged proteins in gels and membranes using a UV-excitable dye and a multiple chelator head pair
- (2020) Vlad-Stefan Raducanu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism
- (2020) Qingxin Zhou et al. JOURNAL OF EXPERIMENTAL MEDICINE
- DFG-1 residue controls inhibitor binding mode and affinity providing a basis for rational design of kinase inhibitor selectivity
- (2020) Martin Schröder et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of Potent PfCLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials
- (2020) Amit Mahindra et al. JOURNAL OF MEDICINAL CHEMISTRY
- Proline Hydroxylation Primes Protein Kinases for Autophosphorylation and Activation
- (2020) Sang Bae Lee et al. MOLECULAR CELL
- Selective DYRK1A Inhibitor for the Treatment of Neurodegenerative Diseases: Alzheimer, Parkinson, Huntington, and Down Syndrome
- (2020) Robert B. Kargbo ACS Medicinal Chemistry Letters
- Multi-layered proteomic analyses decode compositional and functional effects of cancer mutations on kinase complexes
- (2020) Martin Mehnert et al. Nature Communications
- Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome mice
- (2020) Charles R. Goodlett et al. Scientific Reports
- Mitochondrial Stress–Mediated Targeting of Quiescent Cancer Stem Cells in Oral Squamous Cell Carcinoma
- (2020) Tajindra Singh Saluja et al. Cancer Management and Research
- Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors
- (2020) Manuel Saldivia et al. Nature Microbiology
- The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities
- (2020) Jacopo Boni et al. Cancers
- DYRK1A: a down syndrome-related dual protein kinase with a versatile role in tumorigenesis
- (2020) Amina Jamal Laham et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- DYRK2 controls a key regulatory network in chronic myeloid leukemia stem cells
- (2020) Chun Shik Park et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- MicroRNA‐215‐5p inhibits the proliferation of keratinocytes and alleviates psoriasis‐like inflammation by negatively regulating DYRK1A and its downstream signalling pathways
- (2020) Aimin Liu et al. EXPERIMENTAL DERMATOLOGY
- The USP22 promotes the growth of cancer cells through the DYRK1A in pancreatic ductal adenocarcinoma
- (2020) Zhile Bai et al. GENE
- Cdc-Like Kinases (CLKs): Biology, Chemical Probes, and Therapeutic Potential
- (2020) Paula Martín Moyano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Synergistic apoptotic effects in cancer cells by the combination of CLK and Bcl-2 family inhibitors
- (2020) Aiko Murai et al. PLoS One
- The stress-responsive kinase DYRK2 activates heat shock factor 1 promoting resistance to proteotoxic stress
- (2020) Rita Moreno et al. CELL DEATH AND DIFFERENTIATION
- More than a zip code: global modulation of cellular function by nuclear localization signals
- (2020) Chih‐Chia Chang et al. FEBS Journal
- Protein phosphatase PPM1B inhibits DYRK1A kinase through dephosphorylation of pS258 and reduces toxic tau aggregation
- (2020) Ye Hyung Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Emerging roles of DYRK2 in cancer
- (2020) Vasudha Tandon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- How to Separate Kinase Inhibition from Undesired Monoamine Oxidase A Inhibition—The Development of the DYRK1A Inhibitor AnnH75 from the Alkaloid Harmine
- (2020) Anne Wurzlbauer et al. MOLECULES
- Expression, purification and crystallization of CLK1 kinase – A potential target for antiviral therapy
- (2020) Noa Dekel et al. PROTEIN EXPRESSION AND PURIFICATION
- Minibrain-related kinase/dual-specificity tyrosine-regulated kinase 1B implication in stem/cancer stem cells biology
- (2020) Nikolaos Kokkorakis et al. World Journal of Stem Cells
- Transcriptional response of human articular chondrocytes treated with fibronectin fragments: an in vitro model of the osteoarthritis phenotype
- (2020) K.S.M. Reed et al. OSTEOARTHRITIS AND CARTILAGE
- Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP/PS1 mice
- (2019) Benoît Souchet et al. Acta Neuropathologica Communications
- Properties of FDA-approved small molecule protein kinase inhibitors
- (2019) Robert Roskoski PHARMACOLOGICAL RESEARCH
- A complex between DYRK1A and DCAF7 phosphorylates the C-terminal domain of RNA polymerase II to promote myogenesis
- (2019) Dan Yu et al. NUCLEIC ACIDS RESEARCH
- New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis
- (2019) Helmi Tazarki et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Nuclear import of the DSCAM‐cytoplasmic domain drives signaling capable of inhibiting synapse formation
- (2019) Sonja M Sachse et al. EMBO JOURNAL
- A TOR-YAK1 signaling axis controls cell cycle, meristem activity and plant growth in Arabidopsis
- (2019) Adam Barrada et al. DEVELOPMENT
- Dyrk3 loss activates the purine metabolism and promotes hepatocellular carcinoma progression
- (2019) Fei Ma et al. HEPATOLOGY
- Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer
- (2019) Shiho Yokoyama-Mashima et al. CANCER LETTERS
- Chronic Dyrk1 Inhibition Delays the Onset of AD-Like Pathology in 3xTg-AD Mice
- (2019) R. Velazquez et al. MOLECULAR NEUROBIOLOGY
- Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment
- (2019) V. Deshmukh et al. OSTEOARTHRITIS AND CARTILAGE
- The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair
- (2019) Steven E. Guard et al. Scientific Reports
- A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response
- (2019) Julia Roewenstrunk et al. Scientific Reports
- Mutations of the AtYAK1 Kinase Suppress TOR Deficiency in Arabidopsis
- (2019) Céline Forzani et al. Cell Reports
- Regulation of influenza A virus mRNA splicing by CLK1
- (2019) Anita Artarini et al. ANTIVIRAL RESEARCH
- KLF4 Represses DYRK2 Inhibition of Self-renewal and Survival Through c-Myc and p53 in Leukemia Stem/Progenitor Cells
- (2019) Chun Shik Park et al. BLOOD
- The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models
- (2019) Betty Y. Tam et al. CANCER LETTERS
- Multiple functions of DYRK2 in cancer and tissue development
- (2019) Saishu Yoshida et al. FEBS LETTERS
- Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target
- (2019) Mahmood M. Alam et al. SCIENCE
- Upregulated Expression of MicroRNA-204-5p Leads to the Death of Dopaminergic Cells by Targeting DYRK1A-Mediated Apoptotic Signaling Cascade
- (2019) Ching-Chi Chiu et al. Frontiers in Cellular Neuroscience
- Structural Basis for the Selective Inhibition of Cdc2-Like Kinases by CX-4945
- (2019) Joo Youn Lee et al. Biomed Research International
- DYRK1A aggravates β cell dysfunction and apoptosis by promoting the phosphorylation and degradation of IRS2
- (2019) Mei Lu et al. EXPERIMENTAL GERONTOLOGY
- [b]-Annulated Halogen-Substituted Indoles as Potential DYRK1A Inhibitors
- (2019) Christian Lechner et al. MOLECULES
- Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression
- (2019) Sourav Banerjee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CLK3 Is A Direct Target Of miR-144 And Contributes To Aggressive Progression In Hepatocellular Carcinoma
- (2019) Hua Li et al. OncoTargets and Therapy
- Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling
- (2019) Steven E. Guard et al. Jove-Journal of Visualized Experiments
- Licocoumarone induces BxPC-3 pancreatic adenocarcinoma cell death by inhibiting DYRK1A
- (2019) Chao Zhao et al. CHEMICO-BIOLOGICAL INTERACTIONS
- The Dual-Specificity Kinase DYRK1A Modulates the Levels of Cyclin L2 To Control HIV Replication in Macrophages
- (2019) Javan K. Kisaka et al. JOURNAL OF VIROLOGY
- Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
- (2019) Mike A Nalls et al. LANCET NEUROLOGY
- Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update
- (2019) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Sequential phosphorylation of NDEL1 by the DYRK2-GSK3β complex is critical for neuronal morphogenesis
- (2019) Youngsik Woo et al. eLife
- Anti-influenza effect and action mechanisms of the chemical constituent gallocatechin-7-gallate from Pithecellobium clypearia Benth
- (2018) Chao Li et al. ACTA PHARMACOLOGICA SINICA
- Halogen-Aromatic π Interactions Modulate Inhibitor Residence Times
- (2018) Christina Heroven et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells
- (2018) Elizabeth Bowler et al. BMC CANCER
- X-ray structures and feasibility assessment of CLK2 inhibitors for Phelan McDermid syndrome
- (2018) Andreas Markus Lerchner et al. ChemMedChem
- Synthesis and Evaluation of the Anticancer and Trypanocidal Activities of Boronic Tyrphostins
- (2018) Noemi de J. Hiller et al. ChemMedChem
- Anti‐tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC‐dependent vulnerability
- (2018) Kenichi Iwai et al. EMBO Molecular Medicine
- CLK2 blockade modulates alternative splicing compromising MYC‐driven breast tumors
- (2018) Fernando Salvador et al. EMBO Molecular Medicine
- Autoregulation of the human splice factor kinase CLK1 through exon skipping and intron retention
- (2018) Simon Uzor et al. GENE
- Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics
- (2018) Dnyandev B. Jarhad et al. JOURNAL OF MEDICINAL CHEMISTRY
- Crystal Structure of Human Dual-Specificity Tyrosine-Regulated Kinase 3 Reveals New Structural Features and Insights into its Auto-phosphorylation
- (2018) Kuglae Kim et al. JOURNAL OF MOLECULAR BIOLOGY
- Synthetic Lethal Strategy Identifies a Potent and Selective TTK and CLK2 Inhibitor for Treatment of Triple-negative Breast Cancer with a Compromised G1/S Checkpoint
- (2018) Dan Zhu et al. MOLECULAR CANCER THERAPEUTICS
- Kinase inhibitors: the road ahead
- (2018) Fleur M. Ferguson et al. NATURE REVIEWS DRUG DISCOVERY
- Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A gene
- (2018) Susana García-Cerro et al. NEUROBIOLOGY OF DISEASE
- Up-regulation of Dyrk1b promote astrocyte activation following lipopolysaccharide-induced neuroinflammation
- (2018) Mingqing He et al. NEUROPEPTIDES
- Alzheimer’s disease susceptibility genes modify the risk of Parkinson disease and Parkinson’s disease-associated cognitive impairment
- (2018) Lu Fang et al. NEUROSCIENCE LETTERS
- A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee
- (2018) V. Deshmukh et al. OSTEOARTHRITIS AND CARTILAGE
- Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype
- (2018) Anne Walter et al. PLoS One
- DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives
- (2018) Fernanda Neumann et al. Scientific Reports
- Functional characterization of DYRK1A missense variants associated with a syndromic form of intellectual deficiency and autism
- (2018) Esti Wahyu Widowati et al. Biology Open
- Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A
- (2018) Thu Lan Nguyen et al. Disease Models & Mechanisms
- DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective
- (2018) Ankita Pathak et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors
- (2018) Anna Czarna et al. JOURNAL OF MEDICINAL CHEMISTRY
- Kinase-controlled phase transition of membraneless organelles in mitosis
- (2018) Arpan Kumar Rai et al. NATURE
- DYRK1A and cognition: A lifelong relationship
- (2018) Maria L. Arbones et al. PHARMACOLOGY & THERAPEUTICS
- Furo[3,2-b ]pyridine: A Privileged Scaffold for Highly Selective Kinase Inhibitors and Effective Modulators of the Hedgehog Pathway
- (2018) Václav Němec et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Short-term administration of iso-α-acids increases transthyretin transcription in the hippocampus
- (2018) Takafumi Fukuda et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Combined Inhibition of DYRK1A, SMAD, and Trithorax Pathways Synergizes to Induce Robust Replication in Adult Human Beta Cells
- (2018) Peng Wang et al. Cell Metabolism
- DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth
- (2018) Jeroni Luna et al. GUT
- Human cytomegalovirus utilises cellular dual-specificity tyrosine phosphorylation-regulated kinases during placental replication
- (2018) Stuart T. Hamilton et al. PLACENTA
- ANGUSTIFOLIA Regulates Actin Filament Alignment for Nuclear Positioning in Leaves
- (2018) Kosei Iwabuchi et al. PLANT PHYSIOLOGY
- DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B
- (2018) Mina Yousefelahiyeh et al. PLoS One
- Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature
- (2017) Thu Lan Nguyen et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- A wake-up call to quiescent cancer cells - potential use of DYRK1B inhibitors in cancer therapy
- (2017) Walter Becker FEBS Journal
- Structural analysis of pathogenic mutations in theDYRK1Agene in patients with developmental disorders
- (2017) Jochem M.G. Evers et al. HUMAN MOLECULAR GENETICS
- Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis
- (2017) Yingying Chen et al. HUMAN PATHOLOGY
- Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma
- (2017) Qingqing Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen
- (2017) Jennifer R. Riggs et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Potent and Selective Inhibitors of Cdc2-Like Kinase 1 (CLK1) as a New Class of Autophagy Inducers
- (2017) Qi-Zheng Sun et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clk1-regulated aerobic glycolysis is involved in glioma chemoresistance
- (2017) Li Zhang et al. JOURNAL OF NEUROCHEMISTRY
- Disease Association and Druggability of WD40 Repeat Proteins
- (2017) Richard Song et al. JOURNAL OF PROTEOME RESEARCH
- Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes
- (2017) Susana García-Cerro et al. NEUROBIOLOGY OF DISEASE
- Regulation of Glioma Cells Migration by DYRK2
- (2017) Yifen Shen et al. NEUROCHEMICAL RESEARCH
- Plant dual-specificity tyrosine phosphorylation-regulated kinase optimizes light-regulated growth and development in Arabidopsis
- (2017) Wen-Yu Huang et al. PLANT CELL AND ENVIRONMENT
- DYRK1A regulates Hap1–Dcaf7/WDR68 binding with implication for delayed growth in Down syndrome
- (2017) Jianxing Xiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The target landscape of clinical kinase drugs
- (2017) Susan Klaeger et al. SCIENCE
- Targeting DYRK1B suppresses the proliferation and migration of liposarcoma cells
- (2017) Hua Chen et al. Oncotarget
- Development of an orally available inhibitor of CLK1 for skipping a mutated dystrophin exon in Duchenne muscular dystrophy
- (2017) Yukiya Sako et al. Scientific Reports
- Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer’s disease
- (2017) N Janel et al. Translational Psychiatry
- Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits
- (2017) Megan Stringer et al. Molecular Genetics & Genomic Medicine
- Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice
- (2017) Xiaomin Yin et al. Scientific Reports
- Hyper-accumulation of starch and oil in a Chlamydomonas mutant affected in a plant-specific DYRK kinase
- (2016) Miriam Schulz-Raffelt et al. Biotechnology for Biofuels
- A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition
- (2016) Hyeongki Kim et al. Disease Models & Mechanisms
- Small-molecule kinase inhibitors: an analysis of FDA-approved drugs
- (2016) Peng Wu et al. DRUG DISCOVERY TODAY
- Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co–crystal structure
- (2016) Yannick J. Esvan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- DYRK1A inhibition as potential treatment for Alzheimer’s disease
- (2016) Silvia Stotani et al. Future Medicinal Chemistry
- Influence of prenatal EGCG treatment andDyrk1adosage reduction on craniofacial features associated with Down syndrome
- (2016) Samantha D. McElyea et al. HUMAN MOLECULAR GENETICS
- An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases
- (2016) Apirat Chaikuad et al. JOURNAL OF MEDICINAL CHEMISTRY
- The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome
- (2016) P Lee et al. LEUKEMIA
- An ID2-dependent mechanism for VHL inactivation in cancer
- (2016) Sang Bae Lee et al. NATURE
- Association of DYRK1A polymorphisms with sporadic Parkinson’s disease in Chinese Han population
- (2016) Luan Cen et al. NEUROSCIENCE LETTERS
- Wdr68 Mediates Dorsal and Ventral Patterning Events for Craniofacial Development
- (2016) Estibaliz Alvarado et al. PLoS One
- CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency
- (2016) Michael Bidinosti et al. SCIENCE
- Selective inhibition of the kinase DYRK1A by targeting its folding process
- (2016) Isao Kii et al. Nature Communications
- Cdc2-like kinase 2 is a key regulator of the cell cycle via FOXO3a/p27 in glioblastoma
- (2016) Soon Young Park et al. Oncotarget
- DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance
- (2016) Wolfgang Gruber et al. Oncotarget
- A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma
- (2016) Aneesha Radhakrishnan et al. Scientific Reports
- DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome
- (2016) Arnaud Duchon et al. Frontiers in Behavioral Neuroscience
- An extensive program of periodic alternative splicing linked to cell cycle progression
- (2016) Daniel Dominguez et al. eLife
- The adaptor protein DCAF7 mediates the interaction of the adenovirus E1A oncoprotein with the protein kinases DYRK1A and HIPK2
- (2016) Florian Glenewinkel et al. Scientific Reports
- CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast Cancer
- (2015) T. Yoshida et al. CANCER RESEARCH
- A Human Interactome in Three Quantitative Dimensions Organized by Stoichiometries and Abundances
- (2015) Marco Y. Hein et al. CELL
- The BioPlex Network: A Systematic Exploration of the Human Interactome
- (2015) Edward L. Huttlin et al. CELL
- DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies
- (2015) Jianling Ji et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25–35 peptide administration in mice
- (2015) Gaëlle Naert et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Arabidopsis Yak1 protein (AtYak1) is a dual specificity protein kinase
- (2015) Dongjin Kim et al. FEBS LETTERS
- Rescue of the abnormal skeletal phenotype in Ts65Dn Down syndrome mice using genetic and therapeutic modulation of trisomicDyrk1a
- (2015) Joshua D. Blazek et al. HUMAN MOLECULAR GENETICS
- Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I
- (2015) Nana Jin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A
- (2015) Hannes Falke et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity
- (2015) Eunju Im et al. JOURNAL OF NEUROCHEMISTRY
- A novel DYRK1A (Dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologiesin vitro
- (2015) Séverine Coutadeur et al. JOURNAL OF NEUROCHEMISTRY
- Quantitative Phosphoproteomics Reveals Pathways for Coordination of Cell Growth and Division by the Conserved Fission Yeast Kinase Pom1
- (2015) Arminja N. Kettenbach et al. MOLECULAR & CELLULAR PROTEOMICS
- Drug Discovery of Host CLK1 Inhibitors for Influenza Treatment
- (2015) Mian Zu et al. MOLECULES
- A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication
- (2015) Peng Wang et al. NATURE MEDICINE
- A historical overview of protein kinases and their targeted small molecule inhibitors
- (2015) Robert Roskoski PHARMACOLOGICAL RESEARCH
- DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications
- (2015) Ramzi Abbassi et al. PHARMACOLOGY & THERAPEUTICS
- FDA-approved small-molecule kinase inhibitors
- (2015) Peng Wu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Inhibition of DYRK1A and GSK3B induces human β-cell proliferation
- (2015) Weijun Shen et al. Nature Communications
- Role of dual specificity tyrosine-phosphorylation-regulated kinase 1B (Dyrk1B) in S-phase entry of HPV E7 expressing cells from quiescence
- (2015) Na Zhou et al. Oncotarget
- The structure of a dual-specificity tyrosine phosphorylation-regulated kinase 1A–PKC412 complex reveals disulfide-bridge formation with the anomalous catalytic loop HRD(HCD) cysteine
- (2015) Marina Alexeeva et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- DYRK1A Controls HIV-1 Replication at a Transcriptional Level in an NFAT Dependent Manner
- (2015) Thijs Booiman et al. PLoS One
- DYRK1A: A Potential Drug Target for Multiple Down Syndrome Neuropathologies
- (2014) Walter Becker et al. CNS & Neurological Disorders-Drug Targets
- DYRK1A phoshorylates histone H3 to differentially regulate the binding of HP1 isoforms and antagonize HP1-mediated transcriptional repression
- (2014) S. M. Jang et al. EMBO REPORTS
- The Molecular Chaperone TRiC/CCT Binds to the Trp-Asp 40 (WD40) Repeat Protein WDR68 and Promotes Its Folding, Protein Kinase DYRK1A Binding, and Nuclear Accumulation
- (2014) Yoshihiko Miyata et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of the SR Protein-Phosphorylating CLK Kinases of Plasmodium falciparum Impairs Blood Stage Replication and Malaria Transmission
- (2014) Selina Kern et al. PLoS One
- Overexpression of Dyrk1A Is Implicated in Several Cognitive, Electrophysiological and Neuromorphological Alterations Found in a Mouse Model of Down Syndrome
- (2014) Susana García-Cerro et al. PLoS One
- Pyrido[2,3-d]pyrimidines: Discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors
- (2013) Kevin Anderson et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Dual Specificity Kinase DYRK3 Couples Stress Granule Condensation/Dissolution to mTORC1 Signaling
- (2013) Frank Wippich et al. CELL
- A novel link of HLA locus to the regulation of immunity and infection: NFKBIL1 regulates alternative splicing of human immune-related genes and influenza virus M gene
- (2013) Jianbo An et al. JOURNAL OF AUTOIMMUNITY
- Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth
- (2013) Natividad Pozo et al. JOURNAL OF CLINICAL INVESTIGATION
- Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans
- (2013) Rafael De la Torre et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Wdr68 Requires Nuclear Access for Craniofacial Development
- (2013) Bingyan Wang et al. PLoS One
- Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs
- (2013) Abhijeet Bakre et al. PLoS One
- Structures of Down Syndrome Kinases, DYRKs, Reveal Mechanisms of Kinase Activation and Substrate Recognition
- (2013) Meera Soundararajan et al. STRUCTURE
- The Protein Interaction Landscape of the Human CMGC Kinase Group
- (2013) Markku Varjosalo et al. Cell Reports
- Dyrk kinases regulate phosphorylation of doublecortin, cytoskeletal organization, and neuronal morphology
- (2012) Tatiana I. Slepak et al. Cytoskeleton
- Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A (Dyrk1A) Modulates Serine/Arginine-rich Protein 55 (SRp55)-promoted Tau Exon 10 Inclusion
- (2012) Xiaomin Yin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- DYRK1A in Down syndrome: an oncogene or tumor suppressor?
- (2012) Yehudit Birger et al. JOURNAL OF CLINICAL INVESTIGATION
- Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome
- (2012) Sébastien Malinge et al. JOURNAL OF CLINICAL INVESTIGATION
- Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B
- (2012) Tania Tahtouh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome
- (2012) Xavier Altafaj et al. NEUROBIOLOGY OF DISEASE
- A Pilot Study Examining Associations between DYRK1A and a-Synuclein Dementias
- (2012) Emma L. Jones et al. Neurodegenerative Diseases
- Library-based Discovery of DYRK1A/CLK1 Inhibitors from Natural Product Extracts
- (2012) Patrick Grabher et al. PLANTA MEDICA
- Deep Evolutionary Conservation of an Intramolecular Protein Kinase Activation Mechanism
- (2012) Jingfen Han et al. PLoS One
- Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases
- (2012) Vassilios Myrianthopoulos et al. ACS Medicinal Chemistry Letters
- DYRK1A binds to an evolutionarily conserved WD40-repeat protein WDR68 and induces its nuclear translocation
- (2011) Yoshihiko Miyata et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Two key genes closely implicated with the neuropathological characteristics in Down syndrome: DYRK1A and RCAN1
- (2011) Joong-Kyu Park et al. BMB Reports
- Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing
- (2011) Oleg Fedorov et al. CHEMISTRY & BIOLOGY
- Two nucleus-localized CDK-like kinases with crucial roles for malaria parasite erythrocytic replication are involved in phosphorylation of splicing factor
- (2011) Shruti Agarwal et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Leucettines, a Class of Potent Inhibitors of cdc2-Like Kinases and Dual Specificity, Tyrosine Phosphorylation Regulated Kinases Derived from the Marine Sponge Leucettamine B: Modulation of Alternative Pre-RNA Splicing
- (2011) Mansour Debdab et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega
- (2011) F. Sievers et al. Molecular Systems Biology
- Genome-Wide Association Study Identifies Single Nucleotide Polymorphism in DYRK1A Associated with Replication of HIV-1 in Monocyte-Derived Macrophages
- (2011) Sebastiaan M. Bol et al. PLoS One
- Differential effect of CLK SR Kinases on HIV-1 gene expression: potential novel targets for therapy
- (2011) Raymond Wong et al. Retrovirology
- Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum
- (2011) Lev Solyakov et al. Nature Communications
- DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles
- (2010) Sergi Aranda et al. FASEB JOURNAL
- Activation, regulation, and inhibition of DYRK1A
- (2010) Walter Becker et al. FEBS Journal
- Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer’s disease
- (2010) Young Shin Ryu et al. JOURNAL OF NEUROCHEMISTRY
- Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication
- (2010) Alexander Karlas et al. NATURE
- Characterization of a Domain That Transiently Converts Class 2 DYRKs into Intramolecular Tyrosine Kinases
- (2010) R. Kinstrie et al. Science Signaling
- Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
- (2010) Yasushi Ogawa et al. Nature Communications
- Jalview Version 2--a multiple sequence alignment editor and analysis workbench
- (2009) A. M. Waterhouse et al. BIOINFORMATICS
- Synthesis and preliminary biological evaluation of new derivatives of the marine alkaloid leucettamine B as kinase inhibitors
- (2009) Mansour Debdab et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Kinase Domain Insertions Define Distinct Roles of CLK Kinases in SR Protein Phosphorylation
- (2009) Alex N. Bullock et al. STRUCTURE
- Genome-Wide Analysis of Histidine Repeats Reveals Their Role in the Localization of Human Proteins to the Nuclear Speckles Compartment
- (2009) Eulàlia Salichs et al. PLoS Genetics
- Targeting Dyrk1A with AAVshRNA Attenuates Motor Alterations in TgDyrk1A, a Mouse Model of Down Syndrome
- (2008) Jon Ortiz-Abalia et al. AMERICAN JOURNAL OF HUMAN GENETICS
- DYRK3 Dual-specificity Kinase Attenuates Erythropoiesis during Anemia
- (2008) Olga Bogacheva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Increased Dosage of Dyrk1A Alters Alternative Splicing Factor (ASF)-regulated Alternative Splicing of Tau in Down Syndrome
- (2008) Jianhua Shi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4
- (2008) J.H. Sitz et al. NEUROSCIENCE
- Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer’s disease
- (2007) Soo-Ryoon Ryoo et al. JOURNAL OF NEUROCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started